Skip to main content

Provider

By Jessica Hagen | 02:32 pm | November 04, 2024
The CRISPR therapy, HG202, was conceived using AI and machine learning and aims to treat individuals with neovascular age-related macular degeneration.
By Jessica Hagen | 12:59 pm | November 04, 2024
Last week, the wearables company announced it opened an investigation into apparent manipulation in trading its common shares following a 1-for-15 reverse stock split.
By Jessica Hagen | 06:20 pm | October 31, 2024
The acquisition of data company Sparta Science will allow Oura to expand its data analytics capabilities and its B2B offerings.
By Jessica Hagen | 02:30 pm | October 31, 2024
The investigation follows shareholder approval of a 1-for-15 reverse stock that took effect earlier this week.
By Jessica Hagen | 10:45 am | October 30, 2024
Vineeta Agarwala, general partner at Andreessen Horowitz (a16z) Bio + Health, sat down with MobiHealthNews to discuss knownwell's expansion into Texas.
By Nathan Eddy | 03:17 pm | October 29, 2024
The acquisition allows Medbridge to expand its AI-enabled body movement analysis offerings for rehabilitation patients.
By Jessica Hagen | 11:34 am | October 29, 2024
Cuban told MobiHealthNews that he advocates for Harris because she announced she would take on non-pass-through PBMs and introduce drug transparency.
By Jessica Hagen | 10:00 am | October 29, 2024
The platform is tailored to give drivers access to healthcare services, including weight loss management and smoking cessation treatments.
By Jessica Hagen | 06:40 pm | October 25, 2024
The employer-focused hybrid care provider will use the funds to scale its operations and expand access to its preventative care model. 
By Nathan Eddy | 04:11 pm | October 25, 2024
Through the collaboration, adult men will now have access to Tolmar's testosterone replacement therapy, Jatenzo, via UpScriptHealth's telehealth platform.